Before that, it had received seed investment from Atal Incubation Center (AIC) – Center for Cellular and Molecular Biology (CCMB), under the Nidhi Seed Support Scheme.
With the intention of eliminating temperature-related damage to sensitive cargo during transportation, ZedBlox developed its patented product,
ActiPod tackles a common health care curse: temperature violations that result in damage to 5-15 percent of vaccines, drugs, biologics, blood and tissue samples, and more, depending on prevailing weather conditions. This damage is not specific to India. It affects access to medical facilities for millions of people worldwide. In addition to preserving the integrity and effectiveness of life-saving cargo in transit and significantly increasing its reach to remote areas, the ActiPod solution reduces transportation costs per trip by 40 percent.
ZedBlox’s innovative technology is incubated in CCMB-AIC, a leading research institute of Govt. of India, under the expert guidance of Dr. N Madhusudana Rao and Dr. Ramjee Pallela, and received the patent in July 2022, marking its uniqueness in the industry. ZedBlox also owes its success to expert support from IITStartups and JioGenNext. ZedBlox has been recognized as one of the “Top 10 Refrigeration Transport Service Companies” by SiliconIndia magazine.
With 3 patents to his name, Rao Korupolu, co-founder and CEO of ZeldBox, brings his knowledge of his MBA from the Indian School of Business and a master’s degree from the
An alumnus of IIT Roorkee’s Electrical Department and a technical expert, the company’s CTO and co-founder,
Investors can buy gold to diversify risk: Quantum AMC
Indigo’s second quarter net loss increases to 15.833 million, excluding forex loss